Participants 38 116 3
preventive pharmacological strategies in elderly patients and associated costs
Participants 325 355 4
hypertension in older patients
Participants 357 749 6
Since 1991, the results of 3 major trials--the British Medical Research Council (MRC) trial of treatment in older adults, the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension) and the Systolic Hypertension in the Elderly Program (SHEP)--have conclusively established the benefits of treating older patients (> 60 years) with both diastolic and isolated systolic hypertension
Participants 1225 1277 3
the treatment of older individuals with hypertension
